Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

ViePax XL 150 mg Prolonged-Release Tablets

Active Ingredient:
venlafaxine hydrochloride
Company:  
Dexcel Pharma Ltd See contact details
ATC code: 
N06AX16
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Letters to HCPs Product Information
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

Venlafaxine hydrochloride – ViePax XL 150 mg prolonged-release tablets - June 2021

ViePax XL 150 mg prolonged-release tablets (PL 14017/0119) will be replaced by the similar product ViePax XL Dexcel 150 mg prolonged-release tablets (14017/0283).

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Dexcel Pharma Ltd
Company image
Address
7, Sopwith Way, Drayton Fields, Daventry, Northamptonshire, NN11 8PB, UK
Telephone
+44 (0)1327 312 266
Fax
+44 (0)1327 312 262
Medical Information e-mail
[email protected]
Medical Information Direct Line
+44 (0) 1748 828 784
WWW
http://www.dexcelpharma.com
Out of Hours Telephone
+44 (0) 1748 828 784
E-mail
[email protected]